These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31372024)

  • 21. Pharmacogenetics of alcohol, nicotine and drug addiction treatments.
    Sturgess JE; George TP; Kennedy JL; Heinz A; Müller DJ
    Addict Biol; 2011 Jul; 16(3):357-76. PubMed ID: 21362114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder.
    Ehrie J; Hartwell EE; Morris PE; Mark TL; Kranzler HR
    Front Psychiatry; 2020; 11():47. PubMed ID: 32116860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
    Soyka M; Friede M; Schnitker J
    Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Benefits in reducing alcohol consumption: how nalmefene can help].
    Bendimerad P; Blecha L
    Encephale; 2014 Dec; 40(6):495-500. PubMed ID: 25454365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
    PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic treatment of alcoholism.
    Anton RF; Schacht JP; Book SW
    Handb Clin Neurol; 2014; 125():527-42. PubMed ID: 25307594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years.
    Blanco-Gandía MC; Rodríguez-Arias M
    Eur J Pharmacol; 2018 Oct; 836():89-101. PubMed ID: 30096298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current pharmacological treatment approaches for alcohol dependence.
    Müller CA; Geisel O; Banas R; Heinz A
    Expert Opin Pharmacother; 2014 Mar; 15(4):471-81. PubMed ID: 24456374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol addiction - the safety of available approved treatment options.
    Antonelli M; Ferrulli A; Sestito L; Vassallo GA; Tarli C; Mosoni C; Rando MM; Mirijello A; Gasbarrini A; Addolorato G
    Expert Opin Drug Saf; 2018 Feb; 17(2):169-177. PubMed ID: 29120249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.
    Cservenka A; Yardley MM; Ray LA
    Am J Addict; 2017 Aug; 26(5):516-525. PubMed ID: 28134463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacogenetics of alcohol use disorder.
    Jones JD; Comer SD; Kranzler HR
    Alcohol Clin Exp Res; 2015 Mar; 39(3):391-402. PubMed ID: 25703505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of alcohol use disorder treatments: an update.
    Hartwell EE; Kranzler HR
    Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):553-564. PubMed ID: 31162983
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacogenetics and the treatment of addiction].
    Schellekens A
    Ned Tijdschr Geneeskd; 2013; 157(23):A5725. PubMed ID: 23739600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.